Das B, Gupta R, Madhubala R
School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.
Pharmacol Res. 1995 Mar-Apr;31(3-4):189-93. doi: 10.1016/1043-6618(95)80017-4.
Difluoromethylornithine (alpha-DFMO), a specific enzyme activated inhibitor of ornithine decarboxylase activity, a bis (benzyl) polyamine analogue (MDL 27695) and chloroquine resulted in a dose-dependent inhibition of the parasite. The IC50 value of alpha-DFMO, MDL 27695 and chloroquine was 1.85 mM, 2.0 microM and 23 ng ml-1 respectively. The combined action of MDL 27695 (3 microM) and chloroquine (5 ng ml-1) on P. falciparum growth showed near additive effect, whereas the combination of alpha-DFMO (1.0 mM) and chloroquine (5 ng ml-1) was more than the effect of each drug individually but not additive. Similarly the combined effect of MDL 27695 (3 microM) and alpha-DFMO (1.0 mM) on P. falciparum growth was not additive. The effect of these inhibitors alone and in combination on polyamine biosynthesis is also reported.
二氟甲基鸟氨酸(α-DFMO),一种鸟氨酸脱羧酶活性的特异性酶激活抑制剂、一种双(苄基)多胺类似物(MDL 27695)以及氯喹对疟原虫产生了剂量依赖性抑制作用。α-DFMO、MDL 27695和氯喹的半数抑制浓度(IC50)值分别为1.85毫摩尔、2.0微摩尔和23纳克/毫升。MDL 27695(3微摩尔)和氯喹(5纳克/毫升)对恶性疟原虫生长的联合作用显示出近似相加效应,而α-DFMO(1.0毫摩尔)和氯喹(5纳克/毫升)的联合作用大于每种药物单独的作用,但并非相加效应。同样,MDL 27695(3微摩尔)和α-DFMO(1.0毫摩尔)对恶性疟原虫生长的联合作用也不是相加的。还报道了这些抑制剂单独及联合使用对多胺生物合成的影响。